<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html id="nojs" xmlns="http://www.w3.org/1999/xhtml" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:og="http://ogp.me/ns#" xml:lang="en-GB" lang="en-GB" xmlns:wb=“http://open.weibo.com/wb”>

<head>

   
  
      
  
                  
  
                  
  
            
  
            
            
    <title>Trials | Full text | Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial</title>
<link rel="shortcut icon" type="image/x-icon" href="/images/icon/10096/favicon.ico" />
<link rel="apple-touch-icon" sizes="72x72" href="/sites/10096/images/70.gif" />
<meta http-equiv="X-UA-Compatible" content="IE=7" />


                
    
		
		
		
		
<!-- <?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
<cc:Work rdf:about="http://www.trialsjournal.com/content/16/1/64">
<cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
</cc:Work>
<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
<cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/>
<cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Notice"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/>
<cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/>
</cc:License>
<item rdf:about="http://www.trialsjournal.com/content/16/1/64">
<title>Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial</title>
<dc:title>Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial</dc:title>
<dc:creator>Sun, Yue-li</dc:creator>
<dc:creator>Hou, Ting</dc:creator>
<dc:creator>Liu, Shu-fen</dc:creator>
<dc:creator>Zhang, Zhong-liang</dc:creator>
<dc:creator>Zhang, Ning</dc:creator>
<dc:creator>Yao, Min</dc:creator>
<dc:creator>Yang, Long</dc:creator>
<dc:creator>Shi, Qi</dc:creator>
<dc:creator>Cui, Xue-jun</dc:creator>
<dc:creator>Wang, Yong-jun</dc:creator>
<dc:identifier>info:doi/10.1186/s13063-015-0568-6</dc:identifier>
<dc:source>Trials 2015, 16:64</dc:source>
<dc:date>2015-02-26</dc:date>

<prism:publicationName>Trials</prism:publicationName>
<prism:publicationDate>2015-02-26</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>1</prism:number>
<prism:section>Study protocol</prism:section>
<prism:startingPage>64</prism:startingPage>
<prism:copyright>2015 Sun et al.; licensee BioMed Central.</prism:copyright>
</item>
</rdf:RDF>
 -->
 
 
<meta name="citation_journal_title" content="Trials" />
<meta name="citation_publisher" content="BioMed Central Ltd" />


<meta name="citation_author" content="Yue-li Sun" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author" content="Ting Hou" />
<meta name="citation_author_institution" content="College of Traditional Chinese Herbal Medicine, Shanghai University of Traditional Chinese Medicine, No. 1200 Cailun Road, Shanghai 201203, P.R. China" />
<meta name="citation_author" content="Shu-fen Liu" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author" content="Zhong-liang Zhang" />
<meta name="citation_author_institution" content="Zhe Jiang Biosia Pharmaceutical Co., Ltd, No.1938 Xinqun Road, Pinghu City, Zhejiang Province, P.R. China" />
<meta name="citation_author" content="Ning Zhang" />
<meta name="citation_author_institution" content="College of Traditional Chinese Herbal Medicine, Shanghai University of Traditional Chinese Medicine, No. 1200 Cailun Road, Shanghai 201203, P.R. China" />
<meta name="citation_author" content="Min Yao" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author" content="Long Yang" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author" content="Qi Shi" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author" content="Xue-jun Cui" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author" content="Yong-jun Wang" />
<meta name="citation_author_institution" content="Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />
<meta name="citation_author_institution" content="Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China" />


<meta name="citation_issn" content="1745-6215" />
<meta name="citation_title" content="Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial" />
<meta name="citation_volume" content="16" />
<meta name="citation_issue" content="1" />
<meta name="citation_date" content="2015-02-26" />
<meta name="citation_firstpage" content="64" />
<meta name="citation_doi" content="10.1186/s13063-015-0568-6" />
<meta name="citation_pdf_url" content="http://www.trialsjournal.com/content/pdf/s13063-015-0568-6.pdf" />
<link rel="alternate" type="application/pdf" title="PDF" href="http://www.trialsjournal.com/content/pdf/s13063-015-0568-6.pdf" />
<meta name="title" content="Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial" />
<meta name="description" content="High incidences of neck pain morbidity are challenging in various situations for populations based on their demographic, physiological and pathological characteristics. Chinese proprietary herbal medicines, as Complementary and Alternative Medicine (CAM) products, are usually developed from well-established and long-standing recipes formulated as tablets or capsules. However, good quantification and strict standardization are still needed for implementation of individualized therapies. The Qishe pill was developed and has been used clinically since 2009. The Qishe pill&rsquo;s personalized medicine should be documented and administered to various patients according to the ancient TCM system, a classification of personalized constitution types, established to determine predisposition and prognosis to diseases as well as therapy and life-style administration. Therefore, we describe the population pharmacokinetic profile of the Qishe pill and compare its metabolic rate in the three major constitution types (Qi-Deficiency, Yin-Deficiency and Blood-Stasis) to address major challenges to individualized standardized TCM." />

<meta name="dc.title" content="Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial" />
<meta name="dc.creator" content="Sun, Yue-li" />
<meta name="dc.creator" content="Hou, Ting" />
<meta name="dc.creator" content="Liu, Shu-fen" />
<meta name="dc.creator" content="Zhang, Zhong-liang" />
<meta name="dc.creator" content="Zhang, Ning" />
<meta name="dc.creator" content="Yao, Min" />
<meta name="dc.creator" content="Yang, Long" />
<meta name="dc.creator" content="Shi, Qi" />
<meta name="dc.creator" content="Cui, Xue-jun" />
<meta name="dc.creator" content="Wang, Yong-jun" />
<meta name="dc.description" content="High incidences of neck pain morbidity are challenging in various situations for populations based on their demographic, physiological and pathological characteristics. Chinese proprietary herbal medicines, as Complementary and Alternative Medicine (CAM) products, are usually developed from well-established and long-standing recipes formulated as tablets or capsules. However, good quantification and strict standardization are still needed for implementation of individualized therapies. The Qishe pill was developed and has been used clinically since 2009. The Qishe pill&rsquo;s personalized medicine should be documented and administered to various patients according to the ancient TCM system, a classification of personalized constitution types, established to determine predisposition and prognosis to diseases as well as therapy and life-style administration. Therefore, we describe the population pharmacokinetic profile of the Qishe pill and compare its metabolic rate in the three major constitution types (Qi-Deficiency, Yin-Deficiency and Blood-Stasis) to address major challenges to individualized standardized TCM." />
<meta name="dc.source" content="Trials 2015 16:64" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="BioMed Central Ltd" />
<meta name="dc.date" content="2015-02-26" />
<meta name="dc.type" content="Study protocol" />
<meta name="dc.identifier" content="10.1186/s13063-015-0568-6" />
<meta name="dc.language" content="en" />
<meta name="dc.copyright" content="2015 Sun et al.; licensee BioMed Central." />
<meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0/" />
<meta name="dc.rightsAgent" content="reprints@biomedcentral.com" />

<meta name="prism.issn" content="1745-6215" />
<meta name="prism.publicationName" content="Trials" />
<meta name="prism.publicationDate" content="2015-02-26" />
<meta name="prism.volume" content="16" />
<meta name="prism.number" content="1" />
<meta name="prism.section" content="Study protocol" />
<meta name="prism.startingPage" content="64" />
<meta name="prism.copyright" content="2015 Sun et al.; licensee BioMed Central." />
<meta name="prism.rightsAgent" content="reprints@biomedcentral.com" />


        <meta name="citation_abstract_html_url" content="http://www.trialsjournal.com/content/16/1/64/abstract" />
            <meta name="citation_fulltext_html_url" content="http://www.trialsjournal.com/content/16/1/64" />
            <link rel='alternate' type='text/xml' title='XML version' href='http://www.trialsjournal.com/content/download/xml/s13063-015-0568-6.xml' />
            <link rel="image_src" href="http://www.trialsjournal.com/content/figures/s13063-015-0568-6-toc.gif" />
    
     <link rel="section" href="http://trialsjournal.com/content/download/supplementary/s13063-015-0568-6-s1.jpeg" title="Additional file 1:" />
    
    
                    
    

<script type="text/javascript">
// must run before css
document.documentElement.id = "js";
</script>



						
   
  
      
  
                  
  
                  
  
            
  
            
            



						
        <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery-1.8.2.min-0.js"></script>

	                <link rel="stylesheet" type="text/css" href="/css/main-0.css" media="screen, print"/>
    
                <link rel="stylesheet" type="text/css" href="/css/plugins-0.css" media="screen, print"/>
    



    

			                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/articles-0.css" media="screen, print"/>
    	

    

    <link rel="stylesheet" type="text/css" href="/css/themes/10096.css" media="screen, print"/>


                <link rel="stylesheet" type="text/css" href="/css/media/print-0.css" media="print"/>
    



<!--[if IE]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie-0.css"/>
    <![endif]-->

<!--[if IE 7]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie7-0.css"/>
    <![endif]-->
			
<script type="text/javascript">
    //configuration
    OAS_url = '//oas.biomedcentral.com/RealMedia/ads/';

	// control of advert's position on page [AMC]
    
    	
	
    OAS_sitepage = "trialsjournal.com/article/10.1186/s13063/015/0568/6";
    	
		OAS_listpos = 'Top,x96,Right3';
	
	
			
		OAS_query = '';
		
	

    OAS_target = '_top';
    //end of configuration
    OAS_version = 10;
    OAS_rn = '001234567890'; OAS_rns = '1234567890';
    OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);
    function OAS_NORMAL(pos) {
		document.write('<a href="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" target="' + OAS_target + '">');
		document.write('<img src="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" border="0"/></a>');
    }
    
	function refererTerms(referer) {

	if(referer.match("q=") != null) {
		referer = referer.split("q=");
		referer = referer[1].split("&");
		referer = referer[0];
	} else {
		referer = referer;
	}

		if(referer.match("%20") != null && referer.match("%20").length >= 1) {
			referer =  referer.replace(/%20/gi,"+");
			return referer;
		} else { 
			return referer; 
		}
	}
 </script>


 <script type="text/javascript">
	// Set the version of JavaScript to 10 for a Browser 'Mozilla/3' on webTV 
    OAS_version = 11;
    if ((navigator.userAgent.indexOf('Mozilla/3') != -1) || (navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)) {
     OAS_version = 10; }
    if (OAS_version >= 11) {
    document.write('<scr' + 'ipt type="text/javascript" src="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/script>'); }
</script>
	
<script type="text/javascript">
    document.write('');
	
    function OAS_AD(pos) {
        if (OAS_version >= 11)
         OAS_RICH(pos);
        else
         OAS_NORMAL(pos);
    }
 </script>
	





<script type="text/javascript">
    jsonLoaders = function(){
        var _loaders = [];
        return {
            register: function(config){
                config.prefix = config.prefix || '/webapi/1.0/blogs/';
                config.feedLength = config.feedLength || 3;

                _loaders.push(config);
            },
            list: function(){return _loaders}
        };
    }();

    function totext() {
	    document.write('<a href="javascript:returnToText();">Return to text</a>');
    }

    function retrieve_doi(){
        var metas = document.getElementsByTagName('meta');
        var i;
        for (i = 0; i < metas.length; i++)
            if (metas[i].getAttribute('name') == "citation_doi")
                break;
        var citation_doi = metas[i].getAttribute('content');
        return citation_doi;
    }

</script>





    <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script>
        <link title="Latest articles" rel="alternate" href="http://www.trialsjournal.com/latest/rss" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Most viewed" rel="alternate" href="http://www.trialsjournal.com/mostviewed/rss/" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Latest comments" rel="alternate" href="http://www.trialsjournal.com/latestcomments/rss" type="application/rss+xml" exposeToHeader="true"/>
    


	<script type="text/javascript">
	var _gaq = _gaq || [];
	_gaq.push(['_setAccount', 'UA-9663741-5']);
	_gaq.push(['_gat._anonymizeIp']);
	_gaq.push(['_setLocalRemoteServerMode']);
	
	/*for cross domain tracking*/
	//_gaq.push(['_setAllowLinker', true]);
    //_gaq.push(['_setDomainName', 'trialsjournal.com']); //this journal's domain
	/**/
	
		_gaq.push(['_trackPageview']); 

	(function() {
		var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);

		//var iframe = document.getElementById('casesdb-search-widget');
		//if(iframe !== null) {
		//	var pageTracker = _gat._getTrackerByName();
		//	iframe.src = pageTracker._getLinkerUrl('http://www.casesdatabase.com/');
		//}
	})();
	</script>

	
        </head>


<body class=" theme    ">


        



   
  
      
  
                  
  
                  
  
            
  
            
            

    

<div id="oas-campaign" style="display:none">trialsjournal.com/article/10.1186/s13063/015/0568/6</div>
<div id="oas-positions" style="display:none">Bottom,Top</div>

<div id="branding" role="banner">
                			
		<dl class="google-ad wide ">
	<dt class="hide">
					<a class="banner-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising"></a>
				
			</dt>
		<dd>

		<!-- OAS AD 'Top' begin -->
		<script type="text/javascript">
		OAS_AD('Top');

		</script>
		<!-- OAS AD 'Top' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad wide noscript">  
    <dt class="hide"></dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0568/6/13565845307@Top?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0568/6/11869328736@Top?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
			            <div class="sup-panel-outer">
        <div class="sup-panel-inner">

            <style>
  #nojs li.greeting, #nojs li#loginLink {display:none;}
</style>


<ul id="login" class="login">

    <noscript><li><a href="/log"><img class="greeting" src="/images/log.gif"/></a></li></noscript>
    
    <li id="welcome"><span id="username"></span></li>

    <li id="loginLink"><a href=""></a></li>
    
    
</ul>

<script>

function login() {

/* cookie getter/setter */
var allCookies = {
  getItem: function (sKey) {
    if (!sKey || !this.hasItem(sKey)) { return null; }
    return unescape(document.cookie.replace(new RegExp("(?:^|.*;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=\\s*((?:[^;](?!;))*[^;]?).*"), "$1"));
  },
  setItem: function (sKey, sValue, vEnd, sPath, sDomain, bSecure) {
    if (!sKey || /^(?:expires|max\-age|path|domain|secure)$/i.test(sKey)) { return; }
    var sExpires = "";
    if (vEnd) {
      switch (vEnd.constructor) {
        case Number:
          sExpires = vEnd === Infinity ? "; expires=Tue, 19 Jan 2038 03:14:07 GMT" : "; max-age=" + vEnd;
          break;
        case String:
          sExpires = "; expires=" + vEnd;
          break;
        case Date:
          sExpires = "; expires=" + vEnd.toGMTString();
          break;
      }
    }
    document.cookie = escape(sKey) + "=" + escape(sValue) + sExpires + (sDomain ? "; domain=" + sDomain : "") + (sPath ? "; path=" + sPath : "") + (bSecure ? "; secure" : "");
  },
  removeItem: function (sKey, sPath) {
    if (!sKey || !this.hasItem(sKey)) { return; }
    document.cookie = escape(sKey) + "=; expires=Thu, 01 Jan 1970 00:00:00 GMT" + (sPath ? "; path=" + sPath : "");
  },
  hasItem: function (sKey) {
    return (new RegExp("(?:^|;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=")).test(document.cookie);
  },
  keys: /* optional method: you can safely remove it! */ function () {
    var aKeys = document.cookie.replace(/((?:^|\s*;)[^\=]+)(?=;|$)|^\s*|\s*(?:\=[^;]*)?(?:\1|$)/g, "").split(/\s*(?:\=[^;]*)?;\s*/);
    for (var nIdx = 0; nIdx < aKeys.length; nIdx++) { aKeys[nIdx] = unescape(aKeys[nIdx]); }
    return aKeys;
  }
};

// converts cookie into js object
function parseCookie(cookie) {

    cookie = cookie.split("&");
    var obj = {};

    for(var i = 0; i < cookie.length; i++) {

        var c = cookie[i].split("=");

        c[0] = c[0].replace('"','');
        
        obj[c[0]] = c[1];

    }
    return obj;
}

    var cookie = allCookies.getItem("bmccookie");

    var obj = (cookie != null) ? parseCookie(cookie) : {};
    

        var welcome = "";

        if(obj.hasOwnProperty("fname")) {

            // insert user welcome
            welcome = obj.fname.replace(/\+/g, " ") + " " + obj['lname'].replace(/\+/g," ");

            if(jQuery("#welcome").length > 0) {
              jQuery("#welcome").prepend("<strong>Welcome</strong> ");
              jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log off");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logoff");

            window.bmcloggedon = true;


        } else if(obj.hasOwnProperty("institution_name")) {

            // insert institution name
            welcome = obj["institution_name"].replace(/\+/g," ");
            
            if(jQuery("#welcome").length > 0) { 
                jQuery("#welcome").prepend("<strong>Welcome</strong> ");
                jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;


        } else {
            jQuery("#welcome").innerHTML = "";
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;

        }


        // if athens login cookie doesn't exist and the athens login link is visible then remove it.
        if(allCookies.hasItem("athens") != true && document.getElementById("loginAthensLink") != null) {
          jQuery("#loginAthensLink").hide();
        }

}

login();


</script>

            <ul class="nav-sup">

    
        <li id="BMC" class="current">
            <a href="http://www.biomedcentral.com/"><span class="img-title">&nbsp;</span>
            <span class="text-title">BioMed Central</span></a>
        </li>
		
        		<li><a href="http://www.biomedcentral.com/journals"><span>Journals</span></a></li>
		
								<li>
				<a href="http://www.biomedcentral.com/gateways"><span>Gateways</span></a>
			</li>
					    	
</ul>
        </div>
    </div>
    <div class="branding-inner">

        

    
<style>
.survey {
	margin: 10px 0;
}
.survey, .survey .survey-sentence {
	font-size: 13px;
}
.survey-button a, .survey-button a:active, .survey-button a:visited, .survey-button a:hover  {
    color: #FFFFFF;
    text-decoration: none;
}
.survey-button {
	background-color: #FFA500;
    border-radius: 5px;
    color: #FFFFFF;
    font-weight: bold;
    font-size: 13px;
    font-weight: bold;
    padding: 5px 13px;
    background: #ef8142; /* Old browsers */
	background: -moz-linear-gradient(top,  #ef8142 0%, #ef8142 50%, #a64510 100%, #a64510 100%); /* FF3.6+ */
	background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#ef8142), color-stop(50%,#ef8142), color-stop(100%,#a64510), color-stop(100%,#a64510)); /* Chrome,Safari4+ */
	background: -webkit-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Chrome10+,Safari5.1+ */
	background: -o-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Opera 11.10+ */
	background: -ms-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* IE10+ */
	background: linear-gradient(to bottom,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* W3C */
	filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ef8142', endColorstr='#a64510',GradientType=0 ); /* IE6-9 */

}
</style>




          <div class="logo">
        <a href="/"><img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" /></a>     
      </div>    
        
                    



            <div id="impact-factor" class="official">
    <img src="/images/branding/official.gif" alt="official impact factor" title="2.12"/>
    <span id="impact-factor-value">2.12</span>
</div>
    
                            

<div class="module search gray small  " role="search">
    <div class="module-inner padded">
        <form method="get" class="searchForm"
              action=" /quickSearchRedirectURL "
              onsubmit="window.location.href=this['url'].value + '?terms=' + encodeURIComponent(this['terms'].value); return false;">
            <fieldset class="search">
			                <span>
                    Search <select name="url">
                                <option value="http://www.trialsjournal.com/search/results" selected>Trials</option>
                                <option value="http://www.biomedcentral.com/search/results">BioMed Central</option>
                           </select> for
                </span>
                            <input id="searchTerms" name="terms" type="text" alt="Search terms" class="text " />
                 <button class="w37" value="Go" type="submit">Go</button>
            </fieldset>
        </form>
    </div>
	<a class="advanced-search" href="/search">Advanced search</a>
</div> 

                        <div id="mobile-nav-list" >

	<ul class="primary-nav" role="navigation">
		<li     ><a href="/"><span id="home-tab">Home</span></a></li>
														<li             class="current"
    ><a href="/content"><span id="articles-tab">Articles</span></a></li>
										
	

	
            <li     ><a href="/authors/instructions"><span id="authors-tab">Authors</span></a></li>
        <li     ><a href="/about/reviewers"><span id="reviewers-tab">Reviewers</span></a></li>
    		<li     ><a href="/about"><span id='about-tab'>About this journal</span></a></li>
	<li     ><a href="/my"><span id="my-tab">My Trials</span></a></li>
		
    		</ul>
</div>
            </div>
</div>

<hr class="hide" />
<div class="container">
	<div id="content"  class="overflow-visible"  role="main">
			    
	

<!--div class="branding-mobile">
		<h1 class="logo">
	    <a href="/">
		    <img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" />
		</a>
		</h1>
	</div><br/-->



			
	



<div class="outline-wrapper block mobile-hidden" id="left-article-box">
<ul id="box-outline" class="box">
<ul id="outline" class="outline">
   <li>
      <a href="#">Top</a>
   </li>
   <li>
      <a href="#abs">Abstract</a>
   </li>
   <li>
      <a href="#sec1">Background</a>
   </li>
   <li>
      <a href="#sec2">Methods/Design</a>
   </li>
   <li>
      <a href="#sec3">Discussion</a>
   </li>
   <li>
      <a href="#sec4">Trial status</a>
   </li>
   <li>
      <a href="#sec5">Abbreviations</a>
   </li>
   <li>
      <a href="#sec6">Competing interests</a>
   </li>
   <li>
      <a href="#sec7">Authors’ contributions</a>
   </li>
   <li class="long">
      <a href="#sec8" class="clipped" onmouseover="outlineover(this)" onmouseout="outlineout(this)" title="Authors’ information">Authors’ info...</a>
   </li>
   <li class="long">
      <a href="#sec9" class="clipped" onmouseover="outlineover(this)" onmouseout="outlineout(this)" title="Additional file">Additional fi...</a>
   </li>
   <li>
      <a href="#ack">Acknowledgements</a>
   </li>
   <li class="lowest">
      <a href="#refs">References</a>
   </li>
</ul>
</ul>

<dl id="box-outline1">
</dl>

				



</div>



<div class="mobile-hidden" id="right-panel">
 	
<div id="mobile-sidebar">
	<div id="mobile-sidebar-tab">
		<span>
			<a href="#" id="mobile-sidebar-tab-link"><img src="/images/sidebar-hidden.png"><img style="display:none;" src="/images/sidebar-shown.png"></a>
		</span>
	</div>	<div id="mobile-sidebar-list">

<div id="article-navigation-bar">
    <div class="issue-information block">
        <h5><a href="http://www.trialsjournal.com"><strong>Trials</strong></a></h5>
 		        <ul class="square normal">
            <li><a href="http://www.trialsjournal.com/content/16">Volume 16</a></li>
				
                    </ul>
    </div>

    <div class="article-information block" id="article-info">
        


<div id="viewing-options-links">
	<h5>Viewing options</h5>
	<ul class="square normal">
        
            <li>
                             <a onclick="_gaq.push(['_trackEvent', 'Abstract', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/abstract">Abstract</a>
                        </li>
        				<li>
							<strong>Full text</strong>
					</li>
				
		<li class="pdfFileSize">
			<a onclick="_gaq.push(['_trackEvent', 'PDF download', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/pdf/s13063-015-0568-6.pdf">PDF</a>
			<span>(1.4MB)</span>
		</li>

        
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'additional files', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/additional">Additional files</a>
					</li>
			</ul>

        
</div>
		
<div id="associated-material-links">
    <h5>Associated material</h5>
    <ul class="square normal">
                                    <li><a onclick="_gaq.push(['_trackEvent', 'Article metrics', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/about">Article metrics</a></li>
                <li>
                        <a onclick="_gaq.push(['_trackEvent', 'Readers comments', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/comments">Readers' comments </a>
                    </li>
        <li>
                            <a onclick="_gaq.push(['_trackEvent', 'Pre-publication history', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/prepub">Pre-publication history</a>                    </li>
    </ul>
</div>
		




<div id="related-literature-links">
    <h5>Related literature</h5>
    <ul class="normal">
                    <li><a onclick="_gaq.push(['_trackEvent', 'Citied by', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.trialsjournal.com/content/16/1/64/about#citations">Cited by</a></li>
                <li id="google-blog-search"><a onclick="_gaq.push(['_trackEvent', 'Google blog search', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.google.com/search?tbm=blg&hl=en&amp;source=hp&amp;biw=1280&amp;bih=899&amp;q=%22Population+pharmacokinetic+modeling+of+the+Qishe+pill+in+three+major+traditional+Chinese+medicine-defined+constitutional+types+of+healthy+Chinese+subjects%3A+study+protocol+for+a+randomized+controlled+trial%22&amp;btnG=Search">Google blog search</a></li>
        <h6>Other articles by authors</h6>
        <li>
            <a class="collapser"><i>&nbsp;</i>on Google Scholar</a>
<ul id="authg" class="hidebeforeload">                         <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22Y+Sun%22">Sun Y</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22T+Hou%22">Hou T</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22S+Liu%22">Liu S</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22Z+Zhang%22">Zhang Z</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22N+Zhang%22">Zhang N</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22M+Yao%22">Yao M</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22L+Yang%22">Yang L</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22Q+Shi%22">Shi Q</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22X+Cui%22">Cui X</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22Y+Wang%22">Wang Y</a>
            </li>
            </ul>          </li>
                <li>
            	        </li>
    </ul>     <h6>Related articles/pages</h6>
    <ul class="square normal">
        <li><a onclick="_gaq.push(['_trackEvent', 'on google', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.google.co.uk/search?hl=en&amp;q=related:http://www.trialsjournal.com/content/16/1/64">on Google</a></li>
        <li><a onclick="_gaq.push(['_trackEvent', 'on google scholar', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://scholar.google.com/scholar?q=related:http://www.trialsjournal.com/content/16/1/64">on Google Scholar</a></li>
            </ul>

</div>		
        
    
    
        

    	






<h5>Tools</h5>
	<ul class="square normal">
									<li>
						<a onclick="_gaq.push(['_trackEvent', 'download references', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/citation">Download references</a>
					</li>
				<li><a onclick="_gaq.push(['_trackEvent', 'download xml', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/download/xml/s13063-015-0568-6.xml">Download XML</a></li>
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'email2friend', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/email">Email to a friend</a>
					</li>
		<li><a onclick="_gaq.push(['_trackEvent', 'order reprints', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186/s13063-015-0568-6&volume=16&issue=1&title=Population+pharmacokinetic+modeling+of+the+Qishe+pill+in+three+major+traditional+Chinese+medicine-defined+constitutional+types+of+healthy+Chinese+subjects%3A+study+protocol+for+a+randomized+controlled+trial&author_name=Yue-li Sun&start_page=1&end_page=10">Order reprints</a></li>
		<li>
						<a onclick="_gaq.push(['_trackEvent', 'post a comment', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/postcomment">Post a comment</a>
					</li>			
		<ul id="download-to-links">
			<a class="downloadto_title btn" href="#"><span class="icon">&nbsp;</span>Download to ...</a>
			
			<ul id="downloadto" class="iconlist hidebeforeload" style="display: none;">
				<li>
					<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F64" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/64', 1, true]);"><span class="share-icons papers"></span>Papers</a>
				</li>
				<li>
					<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/64" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/64', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
				</li>
			</ul>
		</ul>
		
		<ul id="mobile-downloadto" class="iconlist">
		
		<h6>Download to ...</h6>
			<li>
				<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F64" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/64', 1, true]);"><span class="share-icons papers"></span>Papers</a>
			</li>
			
			<li>
				<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/64" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/64', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
		</ul>

		
	</ul>
		




<h5>Share this article</h5>
<ul id="social-networking-links">
	<li>
	<div class="fb-like" onclick="_gaq.push(['_trackEvent', 'Facebook Recommend', 'Article Sidebar', '/content/16/1/64', 1, true]);" data-href="http://www.trialsjournal.com/content/16/1/64" data-send="false" data-layout="button_count" data-width="100" data-show-faces="false" data-action="recommend"></div>
	</li>
	<li>
		<a onclick="_gaq.push(['_trackEvent', 'Share Twitter Recommend', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://twitter.com/share" data-url="http://www.trialsjournal.com/content/16/1/64" data-counturl="http://www.trialsjournal.com/content/16/1/64" data-hashtags="trials
" data-text="Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial" class="twitter-share-button">Tweet</a>
	</li>
	<li>
			<g:plusone size="medium" width="100"></g:plusone>
	</li>

        <li>
        <wb:share-button onclick="_gaq.push(['_trackEvent', 'Recommend Google plus', 'Article Sidebar', '/content/16/1/64', 1, true]);" addition="number" type="button" ralateUid="2216240737" title="Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial http://www.trialsjournal.com/content/16/1/64"></wb:share-button>
    </li>
    
		<a class="sharethis_title btn" href="#"><span class="icon">&nbsp;</span>More options...</a>
	<ul class="iconlist hidebeforeload" id="sharethis">
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'citeu Like', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.citeulike.org/posturl?url=http://www.trialsjournal.com/content/16/1/64"><span class="share-icons citeulike"></span>Citeulike</a>
			</li>
				<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Linkedin', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.linkedin.com/shareArticle?mini=true&url=%26%2335%3Btrials%0D%0APopulation%20pharmacokinetic%20modeling%20of%20the%20Qishe%20pill%20in%20three%20major%20traditional%20Chinese%20medicine-defined%20constitutional%20types%20of%20healthy%20Chinese%20subjects%3A%20study%20protocol%20for%20a%20randomized%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F64&title=Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial"><span class="share-icons linkedin"></span>LinkedIn</a>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share delicious', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://del.icio.us/post?url=http://www.trialsjournal.com/content/16/1/64&title=Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial"><span class="share-icons delicious"></span>Del.icio.us</a>
	</li>
			<li>
				<a onclick="_gaq.push(['_trackEvent', 'Share via email', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="/content/16/1/64/email"><span class="share-icons email"></span>Email</a>
	</li>
			<li>
				<a onclick="target="_blank" onclick="_gaq.push(['_trackEvent', 'Share facebook', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.facebook.com/sharer.php?u=http://www.trialsjournal.com/content/16/1/64"><span class="share-icons facebook"></span>Facebook</a>
	</li>
	<li class="gp">
			<div class="googlehider mobile-hide"> 
				<div class="g-plusone" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus mobile-hide"></span>
				<div class="googlehider2 mobile-hide"> 
				<div class="g-plusone mobile-hide" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus"></span>
				<span class="gp-link"><a  onclick="_gaq.push(['_trackEvent', 'Share google plus', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="#">Google+</a></span>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Mandeley', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/64"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
			<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share twitter icon', 'Article Sidebar', '/content/16/1/64', 1, true]);" href="http://twitter.com/?status=Population%20pharmacokinetic%20modeling%20of%20the%20Qishe%20pill%20in%20three%20major%20traditional%20Chinese%20medicine-defined%20constitutional%20types%20of%20healthy%20Chinese%20subjects%3A%20study%20protocol%20for%20a%20randomized%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F64+%23trials
"><span class="share-icons twitter"></span>Twitter</a>
			</li>

			<li><a href="http://www.reddit.com/submit" onclick="window.location = 'http://www.reddit.com/submit?url=http://www.trialsjournal.com/content/16/1/64'; return false"> <span class="share-icons reddit"></span>Reddit</a>
    </li>






		</ul>
</ul>

    </div>

    
  
        
                
        


















                                                                                
	

	    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="signup-to-etoc" class="button-collection-margins block mobile-border-bottom">	
					<h3>Email updates</h3>
			<p id="receive_issue_alerts_journal_updates_text">Keep up to date with the latest news and content from Trials and BioMed Central.</p>
			
				
<form  id="articleSignupForUpdates"  method="post" action="/signuptoupdates.html">
	<div id="message-box"></div>
    <fieldset class="block-form">
        <input type="text" name="emailAddress" onblur="javascript: if (this.value == '') { this.value = 'email address'; }" onfocus="javascript: if (this.value == 'email address') { this.value = ''; }" value="email address"  class="text " id="email" />
        <input value="" type="hidden" name="returnUrl" id="returnUrl" />
        <input value="xniche-trials" type="hidden" name="listName" id="listName" />
        <input value="Trials" type="hidden" name="journalName" id="journalName" />
        <button onclick="_gaq.push('_trackEvent', 'Signup', 'Signup for Email updates', "Trials");" class="w74 right" type="submit" onmouseover="this.className='w74 hover right'" onmouseout="this.className='w74 right'" value="Sign up">Sign up</button>
    </fieldset>
</form>	
</div>

	


			<div id="advert-offset">
    					
		<dl class="google-ad  ">
	<dt class="hide">
				
					<a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
			</dt>
		<dd>

		<!-- OAS AD 'Right3' begin -->
		<script type="text/javascript">
		OAS_AD('Right3');

		</script>
		<!-- OAS AD 'Right3' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad  noscript">  
    <dt class="hide"><a href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0568/6/16255811662@Right3?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0568/6/11449228857@Right3?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
					</div>
	

	
</div>
		<div class="mobile-sidebar-gradient top"></div>
		<div class="mobile-sidebar-gradient bottom"></div>
	</div>

</div>








 </div>
<div class="rounded custom white article full-text">
<div class="wrap-inner content">
    <div class="padded-inner">            


    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="topmatter">
	


	   






 
  



				<a href="/about/access"><img alt="Open Access" src="/images/articles/openaccess-large.png" class="access mr15"/></a>
					<span class="articletype">Study protocol</span>

<h1>Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial</h1>
        
			<div class="multipleins">
		
	<p class="authors">
        																																																																																																																																																																																																																																																																																																																																													         <strong>Yue-li Sun</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup><sup>&#134;</sup>, <strong>Ting Hou</strong><sup><a href="/content/16/1/64/#ins3">3</a></sup><sup>&#134;</sup>, <strong>Shu-fen Liu</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup>, <strong>Zhong-liang Zhang</strong><sup><a href="/content/16/1/64/#ins4">4</a></sup>, <strong>Ning Zhang</strong><sup><a href="/content/16/1/64/#ins3">3</a></sup>, <strong>Min Yao</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup>, <strong>Long Yang</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup>, <strong>Qi Shi</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup>, <strong>Xue-jun Cui</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup><sup>&#42;</sup> and <strong>Yong-jun Wang</strong><sup><a href="/content/16/1/64/#ins1">1</a></sup><sup><a href="/content/16/1/64/#ins2">2</a></sup><sup>&#42;</sup>	</p>
	
				<div id="affiliations">
		<div class="module gray  inner">
<div class="module-inner padded-inner">
		<ul>
			<li>                                                                                                                        
                                            
                            		<p class="authors" >
							<span>*</span>
												 Corresponding authors:							            Xue-jun  Cui <a href='mailto:13917715524@139.com'>13917715524@139.com</a> -             Yong-jun  Wang <a href='mailto:yjwang8888@126.com'>yjwang8888@126.com</a>    					</p>
      
</li>
			
                                                                                                                                                                                                                                                                                                                    <li>&#134; Equal contributors</li>    		</ul>

		
		 <p class="options"><a class="affiliations-toggle" href="#"><i class="arrow"></i>Author Affiliations</a></p>            <section> 
						<div class="collapsible-content">
							
				<div id="ins_container" style="display: block;">
										    						    <p >
						        <sup id="ins1">1</sup>                                Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China
                            </p>
																    						    <p >
						        <sup id="ins2">2</sup>                                Spine Institute, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai 200032, P.R. China
                            </p>
																    						    <p >
						        <sup id="ins3">3</sup>                                College of Traditional Chinese Herbal Medicine, Shanghai University of Traditional Chinese Medicine, No. 1200 Cailun Road, Shanghai 201203, P.R. China
                            </p>
																    						    <p >
						        <sup id="ins4">4</sup>                                Zhe Jiang Biosia Pharmaceutical Co., Ltd, No.1938 Xinqun Road, Pinghu City, Zhejiang Province, P.R. China
                            </p>
																
				</div>
										<p id="authoremails">            For all author emails, please <a href="/logon">log on</a>.
    </p>
						</div>
			</section>
				</div>
</div>
		</div>
	  </div>

            <section class="cit">
                        <div class="collapsible-content">
        <p><em>Trials</em> 2015, <strong>16</strong>:64&nbsp;
			<span class="pseudotab">doi:10.1186/s13063-015-0568-6</span></p>
	    			<br/><p>Yue-li Sun and Ting Hou contributed equally to this work.</p>	    
    
        
                
		<p>The electronic version of this article is the complete one and can be found online at: <a href="http://www.trialsjournal.com/content/16/1/64">http://www.trialsjournal.com/content/16/1/64</a></p>
		<br/>
                    <table cellspacing="0" cellpadding="0">
        <tbody>
        <tr><td>Received:</td><td>6 November 2014</td></tr>                <tr><td>Accepted:</td><td>16 January 2015</td></tr>        <tr><td>Published:</td><td>26 February 2015</td></tr>        </tbody>
        </table>
    		<!--<br/>-->
		<div  style="line-height:140%">
        <p>
            &copy; 2015 Sun et al.; licensee BioMed Central. <br />
        </p>
					<p>
				This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
			</p>
		    	</div>
	</section>

</div>
<div id="article-body">
    <section><a name="abs"></a><h3>Abstract</h3>
   <div class="collapsible-content">
      <h4>Background</h4>
      <p style="line-height:160%">High incidences of neck pain morbidity are challenging in various situations for populations
         based on their demographic, physiological and pathological characteristics. Chinese
         proprietary herbal medicines, as Complementary and Alternative Medicine (CAM) products,
         are usually developed from well-established and long-standing recipes formulated as
         tablets or capsules. However, good quantification and strict standardization are still
         needed for implementation of individualized therapies. The Qishe pill was developed
         and has been used clinically since 2009. The Qishe pill’s personalized medicine should
         be documented and administered to various patients according to the ancient <em>TCM</em> system, a classification of personalized constitution types, established to determine
         predisposition and prognosis to diseases as well as therapy and life-style administration.
         Therefore, we describe the population pharmacokinetic profile of the Qishe pill and
         compare its metabolic rate in the three major constitution types (<em>Qi-</em>Deficiency, <em>Yin</em>-Deficiency and <em>Blood-</em>Stasis) to address major challenges to individualized standardized TCM.
      </p>
      <h4>Methods/Design</h4>
      <p style="line-height:160%">Healthy subjects (N = 108) selected based on constitutional types will be assessed,
         and standardized pharmacokinetic protocol will be used for assessing demographic,
         physiological, and pathological data. Laboratory biomarkers will be evaluated and
         blood samples collected for pharmacokinetics(PK) analysis and second-generation gene
         sequencing. In single-dose administrations, subjects in each constitutional type cohort
         (N = 36) will be randomly divided into three groups to receive different Qishe pill
         doses (3.75, 7.5 and 15 grams).
      </p>
      <p style="line-height:160%">Multiomics, including next generation sequencing, metabolomics, and proteomics, will
         complement the Qishe pill’s multilevel assessment, with cytochrome P450 genes as targets.
         In a comparison with the general population, a systematic population pharmacokinetic
         (PopPK) model for the Qishe pill will be established and verified.
      </p>
      <h4>Trial registration</h4>
      <p style="line-height:160%">This study is registered at ClinicalTrials.gov, <a href="NCT02294448">NCT02294448</a> <a href="http://www.webcitation.org/query.php?url=NCT02294448&amp;refdoi=10.1186/s13063-015-0568-6" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>.15 November 2014.
      </p>
   </div>
</section><span id="keywords">
   <h5 class="inline">Keywords: </h5>Personalized medicine; Individualized medicine; Traditional Chinese Medicine; Multiomics; Population pharmacokinetics</span><section><a name="sec1"></a><h3>Background</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Neck pain is one of the most common symptoms of cervical spine disease. Many treatments
         are available to patients and considered standard in clinical practice. They include
         common conservative strategies such as medication, physical methods, manual treatments,
         and education of patients. However, current evidence for the management of neck pain
         reveals that conservative interventions, especially Chinese herbal medicine, have
         not been studied in enough detail to assess their efficacy or effectiveness adequately
         <a name="d81947e232"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a>]. Possible reasons for the failure of current clinical practice to effectively manage
         neck pain lie in two main domains: first, the most difficult challenge faced is clinical
         heterogeneity, which appears at many levels, such as in the sample group, type of
         herbal medicine used and outcomes measured <a name="d81947e236"></a>[<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>]; and second, although Chinese proprietary herbal medicines are usually based on well-established
         and long-standing recipes and formulated as tablets or capsules for commerce, convenience
         and/or palatability, good quantification and strict detailed standardization still
         need to be improved.
      </p>
      <p style="line-height:160%">As individualized diagnostic and therapeutic strategies have become a trend in modern
         medicine, they might help improve the efficacy and safety, predicting individual outcome
         and assessing risk, which make individualized prevention and early intervention strategies
         conceivable and practicable. According to the ancient <em>TCM</em> system, a classification of individualized constitution types has been established
         to determine predisposition and prognosis to diseases as well as therapy and life-style
         administration <a name="d81947e245"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. An official Classification and Determination of TCM Constitution <a name="d81947e249"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>] was released by the State Administration of TCM and the constitution branch of the
         Chinese Medical Association in April, 2009. Meanwhile, a standardized scale called
         Constitution in Chinese Medicine Questionnaire (CCMQ) <a name="d81947e253"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>]-<a name="d81947e257"></a>[<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>] was designed based on the above classification. However, its reliability and validity
         has not been verified with comprehensive, large sample size trials. In the clinic,
         it takes a lot of practice for <em>TCM</em> specialists to be really efficient at adopting the four <em>TCM</em> examinations (observation, listening and smelling, inquiring, feeling the pulse and
         palpation) to totally assess the participants and determine their constitutional types
         based on physical, mental, physiological, and pathological attributes, which are called
         <em>Ti Zhi.</em> There are nine kinds of broad constitutional types with a varying degree of predisposition
         to different diseases (Table&nbsp;<a name="d81947e270"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T1">1</a>). Among these, the three most contrasting constitutional types, <em>Qi-</em>Deficiency, <em>Yin</em>-Deficiency and <em>Blood-</em>Stasis, are the most vulnerable to chronic musculoskeletal diseases <a name="d81947e284"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. In the realm of modern predictive medicine, efforts are being directed toward capturing
         disease phenotypes with greater precision for successful identification of markers
         for prospective disease conditions.
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T1','T1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T1"><strong>Table 1.</strong></a> <strong>General characteristics of the nine traditional Chinese medicine</strong><em>(</em><strong>TCM) constitutional types</strong><a name="d81947e300"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>],<a name="d81947e304"></a>[<a onclick="LoadInParent('#B13'); return false;" href="#B13">13</a>],<a name="d81947e308"></a>[<a onclick="LoadInParent('#B14'); return false;" href="#B14">14</a>]
      </div></div>
      <p style="line-height:160%">In the early 1990s, the YQHYTL formula was proposed for neck pain and subsequently
         underwent further investigation to establish the medicine’s efficacy. Based on the
         YQHYTL formula, the Qishe pill (Shanghai Sundise Traditional Chinese Medicine Co.,
         Ltd, China), which is composed of processed <em>Radix Astragali</em>, <em>Muscone, Szechuan Lovage Rhizome</em>, <em>Radix Stephaniae Tetrandrae</em>, <em>Caulis Sinomenii</em>, and <em>Calculus Bovis Artifactus</em> (Table&nbsp;<a name="d81947e604"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T2">2</a>), was developed and has been widely used in clinical settings since 2009 <a name="d81947e608"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>]-<a name="d81947e612"></a>[<a onclick="LoadInParent('#B11'); return false;" href="#B11">11</a>]. The Qishe pill is a thin 0.15 g film-coated pill with a slightly penetrating odor
         and a mildly bitter flavor. Production and processing of the Qishe pill are described
         as follows: (1) the volatile oil is extracted from <em>Szechuan Lovage Rhizome</em> on standby; (2) the remaining drug decoction from <em>Szechuan Lovage Rhizome</em> is mixed with <em>Radix Astragali,</em> which has been soaked for 30 min, and simmered in 10 volumes of water, twice, for
         2 hours each time; (3) the decoction is then vacuum filtrated to a relative density
         of 1.24 to 1.26 (70°C), and ethanol is added to the concentrated decoction to bring
         to a 70% alcohol content; (4) after filtration and concentration (ethanol recovery),
         the remaining sample is vacuum dried and then crushed into a fine powder; (5) from
         this mixture, which contains 14 volumes of 70% ethanol, <em>Radix Stephaniae Tetrandrae</em> and <em>Caulis Sinomenii</em> are extracted with the circumfluent alcohol, three times for 2 hours, concentrated
         with recovery of ethanol, vacuum dried again, and crushed into a fine powder; (6)
         the volatile oil of <em>Szechuan Lovage Rhizome</em> is then mixed with four parts β-cyclodextrin and dried under vacuum; and (7) the
         porphyrized powder of the <em>Calculus Bovis Artifactus</em> and <em>Muscone</em> are mixed with the β-cyclodextrin and the other two fine powders mentioned above,
         pelleted and coated, to obtain the pills called the Qishe pill (drug name).
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T2','T2',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T2"><strong>Table 2.</strong></a> <strong>Standard formula (capsule ingredients)*</strong></div></div>
      <p style="line-height:160%">With the high incidence of neck pain morbidity <a name="d81947e743"></a>[<a onclick="LoadInParent('#B13'); return false;" href="#B13">13</a>]-<a name="d81947e747"></a>[<a onclick="LoadInParent('#B16'); return false;" href="#B16">16</a>], and the wide variety of population properties (age, gender, weight, constitutional
         type, history of disease and life style, etc.) involved, providing an individual patient
         with optimal treatment at a given time is challenging. Therefore, personalized administration
         of the Qishe pill should be documented and practiced with multiple patients. Thus,
         a comprehensive research concerning the population pharmacokinetics (PopPK) of the
         Qishe pill in Chinese subjects should be conducted. In this study, we describe the
         population pharmacokinetic profile of the Qishe pill and compare its extent of metabolism
         in the three major constitution types (<em>Qi-</em>Deficiency, <em>Yin</em>-Deficiency and <em>Blood</em>-Stasis) to address major challenges of individualized and standardized Traditional
         Chinese Medicine into clinical practice, as a pilot trial.
      </p>
   </div>
</section>
<section><a name="sec2"></a><h3>Methods/Design</h3>
   <div class="collapsible-content">
      <h4>Study design</h4>
      <p style="line-height:160%">This single-center, three cohort, open-label, double-Latin-sequence, crossover study
         will be conducted in 108 healthy adult subjects (36 subjects in each cohort) who meet
         the inclusion and exclusion criteria. The experiments will be conducted in accordance
         with good clinical practice procedures, all applicable regulatory requirements, and
         the guiding principles of the Declaration of Helsinki. This study was approved by
         the ethics committee of the institutional review board in Longhua Hospital, Shanghai
         University of TCM (2013-LCSY-064). After completing baseline description of the study
         to the enrolled subjects, written informed consent will be obtained from each of them.
      </p>
      <p style="line-height:160%">The sample size was established according to GCP guidelines of SFDA, which recommend
         8 to 12 subjects in a clinical pharmacokinetic trial. The study will take place at
         the phase I unit of Longhua Hospital, Shanghai University of TCM from Nov. 2014 to
         Dec 2016.
      </p>
      <h4>Study population</h4>
      <h4>Inclusion and exclusion criteria</h4>
      <p style="line-height:160%">We will recruit three main cohorts with confirmed <em>TCM</em> constitutional types: <em>Qi-</em>Deficiency (n = 36), <em>Yin</em>-Deficiency (n = 36) and <em>Blood-</em>Stasis (n = 36). All subjects will be 20 to 35 years old and with normal weight (18.5
         kg/m<sup>2</sup> ≤BMI &lt;23.0 kg/m<sup>2</sup>). The detailed inclusion and exclusion criteria are presented in Table&nbsp;<a name="d81947e800"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T3','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T3">3</a>.
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T3','T3',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T3"><strong>Table 3.</strong></a> <strong>Inclusion and exclusion criteria</strong></div></div>
      <p style="line-height:160%">All subjects will be surveyed beforehand for their demographic characteristics and
         lifestyle patterns. The screening will also include blood tests and the Constitution
         in Chinese Medicine Questionnaire (CCMQ). After exclusion of noneligible participants,
         the remaining subjects will be assigned identification codes.
      </p>
      <h4>Determination of TCM constitution</h4>
      <p style="line-height:160%">According to Classification and Determination of TCM Constitution <a name="d81947e913"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>] released by the State Administration of TCM and the constitution branch of the Chinese
         Medical Association, two TCM specialists will adopt four <em>TCM</em> examinations (observation, listening and smelling, inquiring, feeling the pulse and
         palpation) to totally assess the participants and determine their constitutional types
         based on physical, mental, physiological, and pathological attributes.
      </p>
      <p style="line-height:160%">The <em>TCM</em> specialists involved are qualified traditional Chinese medical doctors licensed by
         the Chinese government, with 6 years of traditional Chinese medicine training, minimum
         3 years of training in <em>TCM</em>, and 9 years of further clinical experience. The constitutional type will be confirmed
         only when both make concordant decisions. The Constitution in Chinese Medicine Questionnaire
         (CCMQ) <a name="d81947e928"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>]-<a name="d81947e932"></a>[<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>] will be used to improve objectiveness in decision-making.
      </p>
      <h4>Study procedures</h4>
      <h4>Laboratory measurements and clinical assessment</h4>
      <p style="line-height:160%">A specific set of laboratory parameters will be measured for every subject on the
         day of recruitment. These parameters include blood count, electrolyte levels, renal
         and liver function parameters, blood lipid amounts. Furthermore, age, gender, history
         of smoking, blood pressure, weight (kg), and height (meters) will be obtained for
         all subjects. Standard operating procedures have been defined for each clinical examination,
         including the measurements of blood pressure, height and weight <a name="d81947e946"></a>[<a onclick="LoadInParent('#B17'); return false;" href="#B17">17</a>].
      </p>
      <h4>Drug administration</h4>
      <p style="line-height:160%">Thirty-six healthy adult subjects in each cohort will be randomly divided into three
         groups to receive three different doses (low, 3.75 g; middle, 7.5 g; or high, 15 g).
         Subjects will be randomly assigned following simple randomization procedures (computerized
         random numbers) to each subgroup. Each dose of the Qishe pill (Shanghai Sundise Traditional
         Chinese Medicine Co., Ltd, China) with the same lot number will be administered orally
         with water (240 ml) after at least 10-hour fast. The low dose (3.75 mg) was calculated
         according to the applicable regulatory guidance <a name="d81947e956"></a>[<a onclick="LoadInParent('#B18'); return false;" href="#B18">18</a>],<a name="d81947e960"></a>[<a onclick="LoadInParent('#B19'); return false;" href="#B19">19</a>], using the No Observable Adverse Effect Level (NOAEL) in the most sensitive species
         (500 mg/kg/day in Sprague–Dawley rats).
      </p>
      <p style="line-height:160%">Subjects will be admitted to the study unit the evening before drug administration.
         On the day of administration, single doses of the Qishe pill will be taken orally,
         1h after a standardized meal. Regular standardized meals will be provided 4 h after
         drug administration. Water is allowed as desired, except for 1 hour before and 2 hours
         after drug administration. The subjects will remain within a supervised investigational
         unit for the subsequent 3-d period for pharmacokinetic study and toxicity monitoring,
         providing 3-day blood and urine samples. Vital signs and clinical laboratory tests
         were done before and at 24 h after dosing. Furthermore, they will be requested to
         return to the study unit 4 d after drug administration for a follow-up visit.
      </p>
      <h4>Sample collection</h4>
      <p style="line-height:160%">For the PK analysis and second-generation gene sequencing, 5 ml blood samples will
         be collected into tubes containing ammonium heparinate and centrifuged immediately
         at 4000 g for 10 min to obtain plasma samples. These samples will be then transferred
         into polypropylene vials and kept at −20°C until analysis. For the 7.5 and 15 g dose
         groups, samples will be collected at dosing (time 0), and 15, 30, 45, 60, 90, 120,
         150, 180, 240, 360, 480, 600, 720, 1440, 2160 and 2880 min.
      </p>
      <p style="line-height:160%">Furthermore, a comprehensive set of biomaterials including EDTA-plasma (6 ml), serum
         (5 ml) and urine (6 ml) will be collected and stored for future laboratory analyses.
      </p>
      <h4>Safety assessments</h4>
      <p style="line-height:160%">Safety and tolerability will be assessed subjectively and objectively. Subjective
         tolerability will be assessed by questioning subjects about any adverse events (AE).
         Objective tolerability will be assessed at scheduled intervals by vital signs (body
         temperature, heart rate and blood pressure), electrocardiograms (ECGs), the examination
         of intravenous infusion sites, and identification of adverse events (AEs). AE information
         will be collected throughout the study, based on spontaneous volunteer reports, interviews,
         clinical examinations and laboratory tests (hematology, serum biochemistry, and urinalysis).
         The investigators will assess all clinical AEs according to the Medical Dictionary
         for Regular Activities criteria, in terms of intensity (mild, moderate, or severe),
         duration, outcome and relationship to the study drug. Those which are life threatening,
         or lead to death, hospitalization, disability, or medical intervention to prevent
         permanent impairment or damage, will be considered as serious adverse events (SAE).
         Each adverse event occurring to a subject has to be recorded in the case-report form.
      </p>
      <p style="line-height:160%">All study procedures are illustrated in Figure&nbsp;<a name="d81947e981"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/figure/F1">1</a>.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/figure/F1','F1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/figure/F1"><img align="top" src="/content/figures/s13063-015-0568-6-1.gif" alt="thumbnail" class="thumbnail"><strong>Figure 1.</strong></a> <strong>Patient flowchart detailing the process, including screening, allocation, and analysis.</strong></div></div>
      <h4>Instrumentation and conditions</h4>
      <p style="line-height:160%">The LC-MS/MS system consists of an ULTIMATE 3000 series UHPLC (Thermo Fisher Scientific,
         USA) coupled to a TSQ QUANTUM ACCESS MAX Mass Spectrometer (Thermo scientific, USA).
         Chromatographic separation will be performed on a Waters Acquity UPLC BEH C18 column
         [100 mm*2.1 mm (i.d.); 1.7μm] (Waters, USA). The standards and samples will be separated
         using a mobile phase consisting of 0.1% formic acid in water (solvent A) and methanol
         (solvent A). The gradient elution program will be: 0–1 min, 20% A; 1–8 min, 20-100%
         A; 8–12 min, 100% A; and then back to 20% A to recondition the column for 4 min. The
         flow rate of the mobile phase will be 0.3 ml/min, with the column temperature maintained
         at 40°C. ESI ionization performed in the positive ion mode with a spray voltage of
         3,000 V and negative mode with a spray voltage of 2500 V will be used. Sheath gas
         pressure and aux gas pressure will be set at 35 psi and 5 psi, respectively. A capillary
         temperature of 350°C will be used. Quantification will be performed in the multiple
         reaction monitoring (MRM) mode. The optimized parameters, such as collision energy
         (CE) and the tube lens for each compound, are summarized in Table&nbsp;<a name="d81947e1002"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T4','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T4">4</a>. Xcalibur (Ver. 2.1; Thermo scientific, USA) is used to control the UHPLC/TSQ Quantum
         system, and to acquire and process data.
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T4','T4',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T4"><strong>Table 4.</strong></a> <strong>Multiple reaction monitoring (MRM) transitions for quantification of the nine target
            compounds</strong></div></div>
      <h4>Analytical assays</h4>
      <p style="line-height:160%">Plasma concentrations and urinary excretion rates of the Qishe pill will be determined
         for up to 48 h using high-performance liquid chromatography with fluorometric detection
         according to a method used previously <a name="d81947e1262"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>].
      </p>
      <p style="line-height:160%">For sample preparation, plasma samples (100 ml) will be mixed with 100 ml of internal
         standard (diphenhydramine, purchased from the National Institutes for Food and Drug
         Control, Beijing, China) working solution. The samples will be extracted with 11:1
         methanol–water (600 ml) by vortex-mixing for 1 min at high speed and centrifugation
         at 12,000xg for 10 min; 20 ml supernatant will be injected in the LC/MS/MS system
         for analysis.
      </p>
      <h4>Pharmacokinetic parameters</h4>
      <p style="line-height:160%">The pharmacokinetic parameters of the Qishe pill will be estimated using noncompartmental
         methods. The actual blood sampling time will be used, and the maximum plasma concentration
         (<em>C</em><sub>max</sub>) and time to maximum concentration (<em>T</em><sub>max</sub>) will be recorded. The area under the plasma concentration-time curve (<em>AUC</em>) will be calculated using the linear trapezoidal rule. The elimination rate constant
         (<em>k</em><sub>e</sub> ) will be estimated from the least-squares regression slope of the terminal plasma
         concentration. The <em>AUC</em> from 0 to infinity (<em>AUC</em><sub>0−∞</sub>) will be calculated by (<em>AUC</em><sub>0→t</sub> + <em>C</em><sub>t</sub> /<em>k</em><sub>e</sub> ) (<em>C</em><sub>t</sub> is the last plasma concentration measured). The elimination half-life (t<sub>1/2</sub>) will be calculated as ln 2/<em>k</em><sub>e</sub>. The distribution volume (DF) will be calculated by Dose/<em>AUC</em>/<em>k</em><sub>e</sub>.
      </p>
      <h4>Deep phenotyping with genomics and functional genomics approaches</h4>
      <p style="line-height:160%">Within pharmacokinetics of the Qishe pill, standardized workflows for the omics characterization
         of biosamples will be developed. Currently, genomic variants will be analyzed for
         144 subjects with the aid of the Human- CoreExome + v1.1-Psych Array. For a subset
         of 144 subjects, whole blood expression data will be generated using Illumina’s HT-12
         bead chips. The findings will be complemented with proteomic and metabolomic data
         using established workflows. Cytochrome P450 genes, such as CYP1A1, CYP1A2, CYP2D6,
         CYP2C9, CYP2C19, CYP2E1, CYP3A4 and CYP3A5, among other, will be the targets.
      </p>
      <p style="line-height:160%">Metabolomics provide comprehensive snapshots of the metabolome of body fluids such
         as plasma or urine. High-throughput metabolomic analyses mainly based on 1H nuclear
         magnetic resonance (NMR) spectroscopy, a nondestructive analysis with minimal preparation
         requirements, will be performed. NMR spectroscopy provides robust and reproducible
         measurements. Mass spectrometry (MS) with high analytical sensitivity will be used
         for additional detailed studies.
      </p>
      <p style="line-height:160%">Integrated analyses of these data for associations with clinical and subclinical phenotypes
         will be performed using the bioinformatics groups of the <em>TCM</em> constitutional type classification.
      </p>
      <h4>Medical informatics and data management</h4>
      <p style="line-height:160%">The PopPK analysis will be performed with NONMEM <a name="d81947e1359"></a>[<a onclick="LoadInParent('#B21'); return false;" href="#B21">21</a>]-<a name="d81947e1363"></a>[<a onclick="LoadInParent('#B23'); return false;" href="#B23">23</a>]. The plasma concentration-time profiles for all constituents and derivatives of the
         Qishe pill will be described by a base structural model using the subroutine ADVAN5
         <a name="d81947e1367"></a>[<a onclick="LoadInParent('#B24'); return false;" href="#B24">24</a>]. The PK structural model will be parameterized in terms of apparent clearance and
         apparent distribution volume (CL/F and V/F), where F is the unknown oral bioavailability;
         the clearance and distribution volume are CL<sub>M</sub> and V<sub>M</sub>, respectively. A Bayesian approach conditioned on the population characteristics
         will be used to estimate specific individual parameters. First-order conditional estimation
         methods (FOCE) and first-order conditional estimation methods with interaction (FOCE-I)
         will be tested during model development. The unexplained random variability in individual
         values of the structural model parameters will be described in the interindividual
         variability (IIV) model.
      </p>
      <p style="line-height:160%">For the final model, a backward elimination process will be employed to identify significant
         covariates. The covariates in the full model will be excluded one by one. The objective
         function value (OFV) will be compared with that of the full model. A covariate will
         be retained in the model when its elimination results in an increase in the OFV of
         7.88 (chi-square, <em>P</em> &lt;0.005, <em>df</em> = 1). We will select the model according to the reduction in the OFV value, goodness-of-fit
         plots, reduction in the IIV of structure model parameters, residual error, robust
         model parameter estimation, and model stability. The architecture and basic elements
         of the PopPK research is illustrated in Figure&nbsp;<a name="d81947e1384"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/figure/F2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/figure/F2">2</a>.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/figure/F2','F2',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/figure/F2"><img align="top" src="/content/figures/s13063-015-0568-6-2.gif" alt="thumbnail" class="thumbnail"><strong>Figure 2.</strong></a> <strong>Architecture and basic elements of the population pharmacokinetic (PopPK) research
            based on medical informatics and data management.</strong></div></div>
   </div>
</section>
<section><a name="sec3"></a><h3>Discussion</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Cervical radiculopathy is a significant public health problem worldwide, accounting
         for 60 to 70% of all cervical spondylopathy cases; it is generally believed that most
         symptoms can be cured or relieved by nonsurgical treatments <a name="d81947e1406"></a>[<a onclick="LoadInParent('#B25'); return false;" href="#B25">25</a>].
      </p>
      <p style="line-height:160%">Previous evidence-based trials have reported that analgesics and nerve-nutrition medicines
         have considerable effects on neck pain. Even though analgesics, such as aspirin, seem
         to be relatively safe, gastrointestinal reactions are often reported after their use
         <a name="d81947e1412"></a>[<a onclick="LoadInParent('#B26'); return false;" href="#B26">26</a>]. Mecobalamin, a neuropathy drug, which relieves neck pain by stimulating the inhibition
         of nerve degeneration and improving the excitability of nerve fibers <a name="d81947e1416"></a>[<a onclick="LoadInParent('#B27'); return false;" href="#B27">27</a>], seems to be ineffective when degeneration occurs.
      </p>
      <p style="line-height:160%">The Qishe pill provides specific benefits for “Qi and Blood”, terms in <em>TCM</em>, meaning that it can profit and activate blood circulation. We have previously shown
         that the Qishe pill reversibly inhibits the NF-κB pathway, which might be an underlying
         mechanism behind its anti-inflammatory potential in disc degeneration <em>in vivo</em><a name="d81947e1427"></a>[<a onclick="LoadInParent('#B28'); return false;" href="#B28">28</a>]. Extensive investigations have confirmed that the Qishe pill has several therapeutic
         features, inhibiting platelet surface activity and platelet aggregation <a name="d81947e1431"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>], reducing the synthesis and release of local PGE <a name="d81947e1435"></a>[<a onclick="LoadInParent('#B30'); return false;" href="#B30">30</a>], decreasing malondialdehyde content in inflammatory exudates <a name="d81947e1439"></a>[<a onclick="LoadInParent('#B31'); return false;" href="#B31">31</a>], and inhibiting the IL-1beta-induced phosphorylation of extracellular signal-regulated
         kinases 1/2 and c-Jun N-terminal kinase <a name="d81947e1444"></a>[<a onclick="LoadInParent('#B32'); return false;" href="#B32">32</a>]<sub>.</sub> These effects include predictable pharmacokinetics (PK) and pharmacodynamics (PD)
         behaviors; in addition, the Qishe pill suppresses acute inflammatory reactions and
         pain events with fewer gastrointestinal discomfort and rash. A simple and sensitive
         method using ultra-high-performance liquid chromatography–tandem mass spectrometry
         (UHPLC–MS/MS) on a reverse-phase C18 column was developed for the simultaneous determination
         of the 19 major components of the Qishe pill <a name="d81947e1450"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>]. This method was successfully validated for the quantification of the 19 components
         in the Qishe pill products, and constitutes a new standard in quality assessment of
         TCM prescriptions containing multiple bioactive components (see Additional file <a name="d81947e1453"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/suppl/S1','',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/suppl/S1">1</a>). Over the last few years, several interactions between the Qishe pill ingredients
         and the pharmacokinetics of flavonoids (calycosin and calycosin-7-o--d-glycoside),
         alkaloids (tetrandrine, fangchinoline, magnoflorine and berberine hydrochloride),
         ferulic acid and glycosides (astragaloside IV, astragalussaponin I and III) have been
         reported <a name="d81947e1457"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>],<a name="d81947e1461"></a>[<a onclick="LoadInParent('#B33'); return false;" href="#B33">33</a>]-<a name="d81947e1466"></a>[<a onclick="LoadInParent('#B37'); return false;" href="#B37">37</a>]. Furthermore, HPLC-TQ/MS was employed to detect the component contents in the Qishe
         pill, whose partial pharmacokinetic parameters are shown in Table&nbsp;<a name="d81947e1469"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T5','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T5">5</a>.
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/table/T5','T5',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/table/T5"><strong>Table 5.</strong></a> <strong>Pharmacokinetic parameter after oral administration of Qishe pill at a dose of 6.33
            g•kg-1 to SD rats (mean ± SD, n = 6)</strong></div></div>
      <p style="line-height:160%">In the pre-trial of limited size (n = 6), accordingly, a UPLC-TQ/MS method for simultaneous
         determination of plasma concentrations of 15 bio-active Qishe pill constituents was
         developed and validated. The results showed that the method was selective, sensitive,
         precise, accurate, and reliable for comparative quantification of ferulic acid, calycosin,
         calycosin glycosides,calycosin-7-O-β-glucoside, ononin, formononetin, astragaloside,
         tetrandrine, fangchinoline base, berberine, tetrahydroberberine, tetrahydropalmatine,
         sinomenine and magnolia base, in human plasma samples. The mean plasma concentration–time
         profiles of the major bio-active components determined after oral administration of
         Qishe pills are illustrated in Figure&nbsp;<a name="d81947e1743"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/figure/F3','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/figure/F3">3</a>.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/figure/F3','F3',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/figure/F3"><img align="top" src="/content/figures/s13063-015-0568-6-3.gif" alt="thumbnail" class="thumbnail"><strong>Figure 3.</strong></a> <strong>Mean plasma concentration-time curves of seven components after oral administration
            of the Qishe pill at medium and high dosages (n = 4).</strong></div></div>
      <p style="line-height:160%">According to the results of the pilot trial, further research should be conducted
         with modified protocol in dosage setting, requirements of sample collection (diet
         specifications, blood-collection time window) and sample processing.
      </p>
      <h4>Highlights</h4>
      <p style="line-height:160%">Diagnosis and treatment based on an overall analysis of the illness and patient’s
         condition is the essence of the <em>TCM</em> theory. Rational medication is dependent upon a basic understanding of the way patients
         handle drugs (pharmacokinetics) and their response to specific drug effects (pharmacodynamics).
         Moreover, <em>TCM</em> constitutional types in traditional Chinese recipes could significantly influence
         the plasma concentration-time and their pharmacokinetic parameters after oral administration
         <a name="d81947e1773"></a>[<a onclick="LoadInParent('#B38'); return false;" href="#B38">38</a>],<a name="d81947e1777"></a>[<a onclick="LoadInParent('#B39'); return false;" href="#B39">39</a>]. As data collection and OMICS analyses in PopPK of the Qishe pill will be processed
         simultaneously, research is focusing on the analyses of PK, OMICS and laboratory data
         to generate new hypotheses for translational research such as individualized dose,
         individualized scope of <em>TCM</em> and trial simulation.
      </p>
      <p style="line-height:160%">The present study will establish three cohorts to detect potential differences in
         pharmacokinetic characteristics of the Qishe pill constituents in the three different
         <em>TCM</em> constitutional types, to assess whether the rate and extent of drug metabolism will
         be altered in <em>Qi-</em>deficiency or <em>Blood</em>-stasis constitutional types. If the differences in the Qishe Pill pharmacokinetics
         among the three major constitutional groups were known, personalized medication strategies
         for people with the three major constitutional types could be provided for the application
         of TCM.
      </p>
   </div>
</section>
<section><a name="sec4"></a><h3>Trial status</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Participant recruitment and prescreening began in December 2014. Blank control serum
         samples have been collected for standardization of the general methodology and normal
         conditions.
      </p>
   </div>
</section>
<section><a name="sec5"></a><h3>Abbreviations</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">AST-III: Astragaloside III</p>
      <p style="line-height:160%">AST-IV: Astragaloside IV</p>
      <p style="line-height:160%"><em>AUC</em> : area under the plasma concentration–time curve
      </p>
      <p style="line-height:160%">BER: Berberine</p>
      <p style="line-height:160%">CA: Cholic acid</p>
      <p style="line-height:160%">CCS: Calycosin</p>
      <p style="line-height:160%">CCSG: Calycosin-7-O-β-D- glucoside</p>
      <p style="line-height:160%">CE: Collision energy</p>
      <p style="line-height:160%"><em>C</em><sub>max</sub>: Maximum plasma concentration
      </p>
      <p style="line-height:160%">DF: Distribution volume</p>
      <p style="line-height:160%">CL/F: Apparent clearance</p>
      <p style="line-height:160%">CL<sub>M</sub>: Clearance
      </p>
      <p style="line-height:160%">DAI: Daidzein</p>
      <p style="line-height:160%">FAN: Fangchinoline</p>
      <p style="line-height:160%">FOCE: First-order conditional estimation methods</p>
      <p style="line-height:160%">FOCE-I: First-order conditional estimation methods with interaction</p>
      <p style="line-height:160%">FOR: Formononetin</p>
      <p style="line-height:160%">GA: Gallic acid</p>
      <p style="line-height:160%"><em>k</em><sub>e</sub>: Elimination rate constant
      </p>
      <p style="line-height:160%">MS: Mass spectrometry</p>
      <p style="line-height:160%">MRM: Multiple reaction monitoring</p>
      <p style="line-height:160%">NMR: Nuclear magnetic resonance</p>
      <p style="line-height:160%">OFV: Objective function value</p>
      <p style="line-height:160%">ONO: Ononin</p>
      <p style="line-height:160%">PAL: Palmatine</p>
      <p style="line-height:160%">PD: Pharmacodynamics</p>
      <p style="line-height:160%">PK: Pharmacokinetics</p>
      <p style="line-height:160%">PopPK: Population pharmacokinetic</p>
      <p style="line-height:160%">SEA: Senkyunolide A</p>
      <p style="line-height:160%">SEI: Senkyunolide I</p>
      <p style="line-height:160%">SIN: Sinomenine</p>
      <p style="line-height:160%">TCM: Traditional Chinese Medicine</p>
      <p style="line-height:160%"><em>T</em><sub>max</sub>: Time to maximum concentration
      </p>
      <p style="line-height:160%">UHPLC–MS/MS: Ultra-high-performance liquid chromatography–tandem mass spectrometry</p>
      <p style="line-height:160%">V/F: Apparent distribution volume</p>
      <p style="line-height:160%">V<sub>M</sub>: Distribution volume
      </p>
      <p style="line-height:160%">5-O-M: 5-O-methylvisammioside</p>
   </div>
</section>
<section><a name="sec6"></a><h3>Competing interests</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The authors declare that they have no competing interests.</p>
   </div>
</section>
<section><a name="sec7"></a><h3>Authors’ contributions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">YLS participated in the study design, drafted the manuscript, and conducted the clinical
         procedure and sample collection. TH participated in the study design, revised the
         manuscript, and conducted the PK analysis and statistical modeling. SFL and ZLZ participated
         in statistical design and conducted the preliminary animal PK/PD analysis. MY and
         LY conducted the clinical procedure and sample collection. QS formulated the Qishe
         pill and provided academic advice in the Qishe pill administration. YJW, NZ and XJC
         gave administrative support for the study. YJW is the general supervisor for this
         research and participated in both the study design and critical revision of the manuscript.
         All authors read and approved the final manuscript.
      </p>
   </div>
</section>
<section><a name="sec8"></a><h3>Authors’ information</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Yue-li Sun and Ting Hou are co-first authors.</p>
   </div>
</section>
<section><a name="sec9"></a><h3>Additional file</h3>
   <div class="collapsible-content"><div class="figs">
      <div class="addfile"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/64/suppl/S1','S1',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/64/suppl/S1"></a><strong>Additional file 1:.</strong> <strong>Typical chromatograms of ultrahigh-performance LC and tandem mass spectrometry (UHPLC-MS/MS)
            for (a) the mixed standard substance and (b) a sample [</strong><a name="d81947e1932"></a>[<a onclick="LoadInParent('#B32'); return false;" href="#B32">32</a>]<strong>].</strong></p><p>
         	Format: JPEG 
         	Size: 2.2MB <a href="/content/supplementary/s13063-015-0568-6-s1.jpeg">Download file</a><span class="open-data-icon"><a href="/about/access/#opendata"><img title="Open Data" alt="Open Data" src="/bmcimages/article/opendata.gif"></a></span></div></div>
   </div>
</section>
<section><a name="ack"></a><h3>Acknowledgements</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The National TCM clinical research base was supported by State Administration of Traditional
         Chinese Medicine; Clinical Research Project of Traditional Chinese Medicine was supported
         by the State Administration of Traditional Chinese Medicine (201107004), “Three-year”
         project for promoting development of TCM in Shanghai (2014-2016) supported by Shanghai
         Municipal Commission of Health and Family Planning(ZY3-CCCX-3-2005); Selection and
         training project for excellent technician of Shanghai University of Traditional Chinese
         Medicine; “Shu Guang” project supported by Shanghai Municipal Education Commission;
         Shanghai Education Development Foundation(10GG20); Longhua Medical Team Project (LYTD-13);
         “Project Grant” supported by National Science Fund of China (81373666); “Innovation
         Team” development projects supported by Ministry of Education (IRT1270); “TCM Key
         projects” were supported by dept. of Science and Technology in Shanghai (14401970401).
      </p>
   </div>
</section>
<section><a name="refs"></a><h3>References</h3>
   <div id="article-references" class="collapsible-content">
      <ol id="references">
         <li id="B1">
            <p><a name="B1"></a> Aker PD,  Gross AR,  Goldsmith CH,  Peloso P: <strong> Conservative management of mechanical neck pain: systematic overview and meta-analysis. </strong><p><em>BMJ</em> 1996,  <strong>313</strong>(7068)<strong>:</strong>1291-6.  <a target="_blank" href="/pubmed/8942688">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=8942688">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B1" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B1','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B2">
            <p><a name="B2"></a>Cui X, Trinh K, Wang YJ. Chinese herbal medicine for chronic neck pain due to cervical
               degenerative disc disease. Cochrane Database Syst Rev. 2010; (1), CD006556
            </p>
         </li>
         <li id="B3">
            <p><a name="B3"></a>Wang Q. Classification of the nine basic TCM constitutional type and based expression
               and diagnosis. J Beijing University Tradit Chin Med. 2005(04); 1-8.
            </p>
         </li>
         <li id="B4">
            <p><a name="B4"></a> Wang Q,  Zhu YB: <strong> Epidemiological investigation of constitutional types of Chinese medicine in general
                  population: Base on 21,948 epidemiological investigation data of nine provinces in
                  China. </strong><p><em>ZhongHuaZhong Yi Yao ZaZhi</em> 2009,  <strong>24</strong><strong>:</strong>7-12.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B4" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B4','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B5">
            <p><a name="B5"></a> Wang Q,  Zhu YB,  Xue HS: <strong> Primary compiling of constitution in Chinese Medicine questionnaire. </strong><p><em>ZhongGuo Lin Chuang Kang Fu</em> 2006,  <strong>10</strong><strong>:</strong>12-4.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B5" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B5','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B6">
            <p><a name="B6"></a> Zhu YB,  Wang Q,  Xue HS,  Origasa H: <strong> Preliminary assessment on performance of constitution in Chinese medicine questionnaire. </strong><p><em>ZhongGuo Lin Chuang Kang Fu</em> 2006,  <strong>10</strong><strong>:</strong>15-7.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B6" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B6','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B7">
            <p><a name="B7"></a> Zhu YB,  Wang Q,  Origasa H: <strong> Evaluation on reliability and validity of the constitution in Chinese medicine questionnaire
                  (CCMQ). </strong><p><em>ZhongGuo Xing Wei Yi XueKeXue</em> 2007,  <strong>16</strong><strong>:</strong>651-4.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B7" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B7','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B8">
            <p><a name="B8"></a> Mei L,  Zhang N,  Wang YJ,  Shi Q: <strong> Purification process research of major compound in Qishe Pill as Astragalus. </strong><p><em>Acta Chin Med Pharmacol</em> 2006,  <strong>34</strong><strong>:</strong>14-6.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B8" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B8','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B9">
            <p><a name="B9"></a> Zhang YQ,  Liu XH,  Zhang N,  Liu M: <strong> Quality standard research of Qishe Pill. </strong><p><em>Lishizhen Med Mater Med Res</em> 2008,  <strong>19</strong><strong>:</strong>977-9.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B9" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B9','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B10">
            <p><a name="B10"></a> Liu M,  Zhang N,  Wang YJ,  Zhang YQ,  Zhou CJ: <strong> Technology research of Qishe Pill, a new medicine for cervical spondylosis. </strong><p><em>Lishizhen Med Mater Med Res</em> 2010,  <strong>21</strong><strong>:</strong>176-9.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B10" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B10','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B11">
            <p><a name="B11"></a> Ge JR,  Wang HM,  Meng CX,  Tong PJ: <strong> Effects of Qishe Pill, a compound traditional Chinese herbal medicine, on cervical
                  radiculopathy: a randomized controlled trial for Phase III. </strong><p><em>Chin J New Drugs Clin</em> 2014,  <strong>7</strong><strong>:</strong>56-8.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B11" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B11','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B12">
            <p><a name="B12"></a> Hsu H-Y: <em>1986 Oriental MateriaMedica</em>.  Oriental Healing Arts Institute, Long Beach, CA;  1986. <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B12" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B12','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B13">
            <p><a name="B13"></a> Maurer K: <strong> U.S. Department of Health, Education, and Welfare. Basic data on arthritis knee, hip
                  and sacroiliac joints in adults ages 25–74 years: United States, 1971–1975. </strong><p><em>Health Stat</em> 1979,  <strong>11</strong><strong>:</strong>1-31.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B13" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B13','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B14">
            <p><a name="B14"></a> Mäkelä M,  Heliövaara M,  Sievers K,  Impivaara O,  Knekt P,  Aromaa A: <strong> Prevalence, determinants, and consequences of chronic neck pain in Finland. </strong><p><em>Am J Epidemiol</em> 1991,  <strong>134</strong><strong>:</strong>1356-67.  <a target="_blank" href="/pubmed/1755449">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=1755449">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B14" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B14','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B15">
            <p><a name="B15"></a> Bovim G,  Schrader H,  Sand T: <strong> Neck pain in the general population. </strong><p><em>Spine (Phila Pa 1976)</em> 1994,  <strong>19</strong><strong>:</strong>1307-9.   <a target="_blank" href="http://dx.doi.org/10.1097/00007632-199406000-00001">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B15" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B15','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B16">
            <p><a name="B16"></a> Van der Donk J,  Schouten JS,  Passchier J,  van Romunde LK,  Valkenburg HA: <strong> The associations of neck pain with radiological abnormalities of the cervical spine
                  and personality traits in a general population. </strong><p><em>J Rheumatol</em> 1991,  <strong>18</strong><strong>:</strong>1884-9.  <a target="_blank" href="/pubmed/1795327">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=1795327">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B16" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B16','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B17">
            <p><a name="B17"></a> Choo V: <strong> WHO reassesses appropriate body-mass index for Asian populations. </strong><p><em>Lancet</em> 2002,  <strong>360</strong><strong>:</strong>235.  <a target="_blank" href="/pubmed/12133671">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12133671">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B17" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B17','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B18">
            <p><a name="B18"></a>FDA/CDER. Guidance for industry estimating the maximum safe starting dose in initial
               clinical trials for therapeutics in adult healthy volunteers; July, 2005, http://www.fda.gov/downloads/drugs/guidance-complianceregulatoryinformation/guidances/ucm078932.pdf.
            </p>
         </li>
         <li id="B19">
            <p><a name="B19"></a>EMEA. Strategies to identify and mitigate risks for first-in-human clinical trialswith
               investigational medicinal products; Sept. 2009, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002988.pdf.
            </p>
         </li>
         <li id="B20">
            <p><a name="B20"></a>Zhang ZL, Li Q, Li QF, Du SM, Zhou YQ, Lv CM, et al. Simultaneous determination of
               nineteen major components in Qishe Pill by ultra-high-performance liquid chromatography–tandem
               mass spectrometry. Acta Pharmaceutica Sinica B (2014); http://www.dx.doi.org/10.1016/j.apsb.2014.05.003
            </p>
         </li>
         <li id="B21">
            <p><a name="B21"></a> Sheiner LB,  Beal SL: <strong> Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten
                  model: routine clinical pharmacokinetic data. </strong><p><em>J Pharmacokinet Biopharm</em> 1980,  <strong>8</strong><strong>:</strong>553-71.  <a target="_blank" href="/pubmed/7229908">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=7229908">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B21" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B21','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B22">
            <p><a name="B22"></a> Sheiner BL,  Beal SL: <strong> Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential
                  model and experi- mental pharmacokinetic data. </strong><p><em>J Pharmacokinet Biopharm</em> 1981,  <strong>9</strong><strong>:</strong>635-51.  <a target="_blank" href="/pubmed/7334463">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=7334463">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B22" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B22','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B23">
            <p><a name="B23"></a> Sheiner LB,  Beal SL: <strong> Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential
                  model: routine clinical pharmacokinetic data. </strong><p><em>J Pharmacokinet Biopharm</em> 1983,  <strong>11</strong><strong>:</strong>303-19.  <a target="_blank" href="/pubmed/6644555">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=6644555">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B23" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B23','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B24">
            <p><a name="B24"></a> Feng Y,  Pollock BG,  Coley K,  Marder S,  Miller D,  Kirshner M, <em>et al</em>.: <strong> Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements
                  from the CATIE study. </strong><p><em>Br J Clin Pharmacol</em> 2008,  <strong>66</strong><strong>:</strong>629-39.  <a target="_blank" href="/pubmed/18771484">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18771484">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B24" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B24','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B25">
            <p><a name="B25"></a> Qingmao Y: <strong> An 80-cases clinical observation of two conservative therapy of traditional Chinese
                  and western medicine to cervical spondylotic radiculopathy. </strong><p><em>Chinese Foreign Health Abs</em> 2010,  <strong>18</strong><strong>:</strong>223-5.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B25" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B25','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B26">
            <p><a name="B26"></a> Bin-Chia Wu D,  Tsai YW,  Wen YW: <strong> Bayesian cost-effectiveness analysis for censored data-an application to antiplatelet
                  therapy. </strong><p><em>J Med Econ</em> 2012,  <strong>15</strong><strong>:</strong>434-43.   <a target="_blank" href="http://dx.doi.org/10.3111/13696998.2011.653510">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B26" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B26','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B27">
            <p><a name="B27"></a> Okada K,  Tanaka H,  Temporin K,  Okamoto M,  Kuroda Y,  Moritomo H, <em>et al</em>.: <strong> Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle
                  and promotes nerve regeneration in a rat sciatic nerve injury model. </strong><p><em>Exp Neurol</em> 2010,  <strong>222</strong><strong>:</strong>191-203.  <a target="_blank" href="/pubmed/20045411">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20045411">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B27" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B27','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B28">
            <p><a name="B28"></a> Zhang WJ,  Hufnagl P,  Binder BR: <strong> Anti-inflammatory activity of astragaloside IV is mediated by inhibition of NF-qB
                  activation and adhesion molecule expression. </strong><p><em>Thromb Haemost</em> 2003,  <strong>90</strong><strong>:</strong>904-14.  <a target="_blank" href="/pubmed/14597987">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=14597987">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B28" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B28','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B29">
            <p><a name="B29"></a> Chen SL,  Jiang GH: <strong> Security and pharmacilogical effects of Szechuan Lovage Rhizome extract. </strong><p><em>J Chengdu UnivTradit Chin Med</em> 2009,  <strong>32</strong><strong>:</strong>63-5.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B29" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B29','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B30">
            <p><a name="B30"></a> Sun X,  Yu XJ,  Qiu MF: <strong> Clinical research progress of the pharmacology of ovientvine. </strong><p><em>J China’s Integrated Tradit Chin Western Med Surg</em> 2005,  <strong>11</strong><strong>:</strong>363-4. 
               <p> [In Chinese]</p> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B30" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B30','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B31">
            <p><a name="B31"></a> Li X,  Yu QH: <strong> Anti-inflammatory effects of Calculus BovisArtifactus: apilot study. </strong><p><em>J Shengyang Pharm Univ</em> 2000,  <strong>17</strong><strong>:</strong>431-3.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B31" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B31','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B32">
            <p><a name="B32"></a> Liang QQ,  Zhang M,  Zhou Q,  Shi Q,  Wang YJ: <strong> Muscone protects vertebral end-plate degeneration by anti-inflammatory property. </strong><p><em>ClinOrthop Relat Res</em> 2010,  <strong>468</strong><strong>:</strong>1600-10.   <a target="_blank" href="http://dx.doi.org/10.1007/s11999-009-1079-0">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B32" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B32','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B33">
            <p><a name="B33"></a> Du SM,  Pan YF,  Zhang N: <strong> Simultaneous determination with HPLC internal standard method for nine kinds ingredients
                  in Qishe Pill. </strong><p><em>Chin Tradit Pat Med</em> 2012,  <strong>7</strong><strong>:</strong>1271-5.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B33" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B33','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B34">
            <p><a name="B34"></a> Li Q,  Du SM,  Li QF,  Zhang ZL,  Zhang N: <strong> Effects of Qishe Pill on cervical radiculopathy rat model with <em>Qi-</em>deficiency and <em>Blood</em>-stasis syndrome. </strong><p><em>Pharmacol Clin</em> 2013,  <strong>4</strong><strong>:</strong>118-21.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B34" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B34','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B35">
            <p><a name="B35"></a> Du SM,  Li Q,  Li QF,  Zhang ZL,  Zhang N: <strong> <em>Invivo</em> tissue distribution research of ingredients in Qishe Pill. </strong><p><em>Chin J Exp Formulas Chin Med</em> 2013,  <strong>19</strong><strong>:</strong>171-6.  <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B35" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B35','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B36">
            <p><a name="B36"></a> Wang D,  Song Y,  Li SL,  Bian YY,  Guan J,  Li P: <strong> Simultaneous analysis of seven astragalosides in Radix Astragali and related preparations
                  by liquid chromatography coupled with electrospray ionization time-of-flight mass
                  spectrometry. </strong><p><em>J Sep Sci</em> 2006,  <strong>29</strong><strong>:</strong>2012-22.  <a target="_blank" href="/pubmed/17017014">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17017014">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B36" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B36','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B37">
            <p><a name="B37"></a> Yu QT,  Qi LW,  Li P,  Yi L,  Zhao J,  Bi ZM: <strong> Determination of seventeen main flavonoids and saponins in the medicinal plant Huang-qi
                  (Radix Astragali) by HPLC-DAD-ELSD. </strong><p><em>J Sep Sci</em> 2007,  <strong>30</strong><strong>:</strong>1292-9.  <a target="_blank" href="/pubmed/17623470">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17623470">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B37" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B37','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B38">
            <p><a name="B38"></a> Huang X,  Ren P,  Wen AD,  Wang LL,  Zhang L,  Gao F: <strong> Pharmacokinetics of traditional Chinese syndrome and recipe: a hypothesis and its
                  verification (I). </strong><p><em>World J Gastroenterol</em> 2000,  <strong>6</strong><strong>:</strong>384-91.  <a target="_blank" href="/pubmed/11819604">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=11819604">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B38" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B38','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B39">
            <p><a name="B39"></a> Tian Y,  Yang ZF,  Li Y,  Qiao Y,  Yang J,  Jia YY, <em>et al</em>.: <strong> Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis
                  syn- drome rats. </strong><p><em>J Ethnopharmacol</em> 2010,  <strong>129</strong><strong>:</strong>1-4.  <a target="_blank" href="/pubmed/20206677">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20206677">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0568-6&amp;bibl=B39" onclick="popup('/sfx_links?ui=s13063-015-0568-6&amp;bibl=B39','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
      </ol>
   </div>
</section>
    <br class="clearall">
<div class="article-alert-signup-div">

<a class="close png_bg" id="closeHelpBox" >close</a>	
<div class="article-alert-signup rounded" > 
<span class="blurb left">Sign up to receive new article alerts from <em>Trials</em></span>

	
				<button name="articleAlertPreference.status" type="button" class="w74 right" onClick="window.location='/my/preferences'">Sign up</button>
	
</div>
</div></div>
    </div></div>
</div>


		</div>
</div>

    <hr class="hide" />
	
    

						
   
  
      
  
                  
  
                  
  
            
  
            
            


<div id="footer">

						
			<span class="views"><a id="mobile-view" href="?fmt_view=mobile">Mobile view</a> | <strong>Desktop view</strong></span>
			
	<div class="content">
    <div class="rounded ">
<div class="wrap-inner ">
        	
    <ul class="desktop">
                                                    
				        <li class="noborder"><a href="http://www.biomedcentral.com/about/tandc">Terms and Conditions</a></li>
<li><a href="http://www.biomedcentral.com/about/privacy">Privacy statement</a></li>
<li><a href="http://www.biomedcentral.com/presscenter">Press</a></li>
	<li><a href="http://www.biomedcentral.com/advertisers">Information for advertisers</a></li>
<li><a href="http://www.biomedcentral.com/about/bmcjobs">Jobs at BMC</a></li>
<li><a href="/support">Support</a></li>
<li><a href="/about/contact">Contact us</a></li>


    
    	    </ul>
    <p id="copyright">&copy; 2015 
	BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business&nbsp;Media.</p>
        </div>
</div>

	</div>

</div>
<div class="springer">
    <a href="http://www.springer.com/" target="blank"><img style="float:right; margin:0;" src="
    //www.biomedcentral.com/images/Springer_Branding_footer_logo.png" /></a>
</div>


<script>window.bmcIsMobile = "classic";</script>					    

<script>
// getElementsByClassName Polyfill
var getElementsByClassName=function(e,t,n){if(document.getElementsByClassName){getElementsByClassName=function(e,t,n){n=n||document;var r=n.getElementsByClassName(e),i=t?new RegExp("\\b"+t+"\\b","i"):null,s=[],o;for(var u=0,a=r.length;u<a;u+=1){o=r[u];if(!i||i.test(o.nodeName)){s.push(o)}}return s}}else if(document.evaluate){getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i="",s="http://www.w3.org/1999/xhtml",o=document.documentElement.namespaceURI===s?s:null,u=[],a,f;for(var l=0,c=r.length;l<c;l+=1){i+="[contains(concat(' ', @class, ' '), ' "+r[l]+" ')]"}try{a=document.evaluate(".//"+t+i,n,o,0,null)}catch(h){a=document.evaluate(".//"+t+i,n,null,0,null)}while(f=a.iterateNext()){u.push(f)}return u}}else{getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i=[],s=t==="*"&&n.all?n.all:n.getElementsByTagName(t),o,u=[],a;for(var f=0,l=r.length;f<l;f+=1){i.push(new RegExp("(^|\\s)"+r[f]+"(\\s|$)"))}for(var c=0,h=s.length;c<h;c+=1){o=s[c];a=false;for(var p=0,d=i.length;p<d;p+=1){a=i[p].test(o.className);if(!a){break}}if(a){u.push(o)}}return u}}return getElementsByClassName(e,t,n)}
</script>

						



<script type="text/javascript">
if (typeof jQuery == 'undefined') { document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.min.js' type='text/javascript'%3E%3C/script%3E")); }


document.documentElement.id = "js";

var site = {
			abbreviation: "",
	        type: "BMC_NICHE",
        portalId: "9001",
                section: "browse",
                page: "fulltext",
    		
									homePortal: "biomedcentral.com",
		
			siteShowAds: "true",
				showAds: "true",
				url: "trialsjournal.com",
			portal: false,
	        adpage_url: "trialsjournal.com/article/10.1186/s13063/015/0568/6",
        id: "10096",
	name: "Trials",
	plugins: {
		scrollable: (getElementsByClassName("scrollable").length > 0),
				flowplayer: ((document.getElementById("flowplayer") != null) || (getElementsByClassName("myPlayer").length > 0) || (document.getElementById("videoarticle") != null) || (getElementsByClassName("flowplayer").length > 0) || (document.getElementById("audio") != null) || (document.getElementById("elifeplayer") != null)),
		lightbox: ((document.getElementById("image-highlight") != null) || (getElementsByClassName("lightbox").length > 0)),
		thickbox: (getElementsByClassName("thickbox").length > 0),
		altmetric: ((document.getElementById("altmetric") != null) || (getElementsByClassName("altmetric").length > 0))
	}
	
};



if(typeof quoteSearchUri == "undefined") { quoteSearchUri=null; }
</script>



        <script type="text/javascript" src="http://www.bmcimg.com/javascript/journals/behaviours-0.js"></script>






		<script>
	if (site.plugins.scrollable == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.scrollable-1.0.1.min.js' %3E%3C/script%3E")); 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.tools.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.flowplayer == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/flowplayer-3.2.6.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.lightbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/browse_imagehighlight.js'%3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.colorbox.js' %3E%3C/script%3E"));
	}

	if (site.plugins.thickbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-compressed.js' %3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-flashhidden-patch.js' %3E%3C/script%3E"));
	}
	</script>





            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.fancybox-1.3.1.pack-0.js"></script>
            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.debug-0.js"></script>
                      <script type="text/javascript" src="http://www.bmcimg.com/javascript/email_preferences/email_preferences-0.js"></script>
                <script type="text/javascript" src="http://www.bmcimg.com/javascript/articles/articles-0.js"></script>
		<div id="fb-root"></div>











        <script type="text/javascript" src="/javascript/plugins/jquery.tagcloud.min-0.js"></script>




<!--[if lte IE 6]>
            <script type="text/javascript" src="/javascript/plugins/DD_belatedPNG_0.0.8a-0.js"></script>
    <script type="text/javascript">
        DD_belatedPNG.fix('.png_bg, ul.primary-nav li a, ul.primary-nav li a span, ul.secondary-nav li a, ul.secondary-nav li a span, ul li i, .plus-button, .facebook, .twitter, .fancy-bg, #fancybox-close');
    </script>
	                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/hacks/ie6-0.css"/>
    <![endif]-->

<!-- Claudia Whitcombe wanted this comment here -->

       <div class="hide">
      <dl class="google-ad" id="x96banner">
        <dt style="display: block;" class="hide">
          <a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
       </dt>
        <dd>
          <!-- OAS AD 'x96' begin -->
          <script type="text/javascript">
            OAS_AD('x96');
          </script>
        </dd>
      </dl>
    </div>  
    
</body>
</html>

